Tempest Therapeutics(TPST.US)

Last Updated 19:00:00 ET
longbridge loading

Tempest Therapeutics | 10-Q: FY2026 Q1 Revenue: USD 0

Earnings Watch·
US
TPST
-4.30%
Earnings Watch·
US
TPST
-4.30%

Tempest Therapeutics | 8-K: FY2026 Q1 Revenue: USD 0

Earnings Watch·
US
TPST
-4.30%
Earnings Watch·
US
TPST
-4.30%

TPST Q1'26 Earnings: revenue estimate is 0 USD

TradingView·
US
TPST
-4.30%
US
SBIO
+0.78%
US
ARKG
+1.49%
TradingView·
US
TPST
-4.30%
US
SBIO
+0.78%
US
ARKG
+1.49%

12 Health Care Stocks Moving In Friday's Intraday Session

benzinga_article·
US
REPL
+2.03%
US
TPST
-4.30%
US
XBI
-0.13%
benzinga_article·
US
REPL
+2.03%
US
TPST
-4.30%
US
XBI
-0.13%

Tempest Therapeutics 10-K: Net loss $26.3M, EPS $(6.33)

TradingView·
US
FBT
+0.04%
US
TPST
-4.30%
US
XLV
+0.14%
TradingView·
US
FBT
+0.04%
US
TPST
-4.30%
US
XLV
+0.14%

Tempest Therapeutics | 10-K: FY2025 Revenue: USD 0

Earnings Watch·
US
TPST
-4.30%
Earnings Watch·
US
TPST
-4.30%

Thursday 3/26 Insider Buying Report: RPC, TPST

nasdaq·
US
BIB
+0.08%
US
XLV
+0.14%
US
PBE
-0.14%
nasdaq·
US
BIB
+0.08%
US
XLV
+0.14%
US
PBE
-0.14%

Top Biotech Insider Quietly Makes a Bold Move That Could Signal What’s Coming Next

Tip Ranks·
US
ARKG
+1.49%
US
BBH
+0.32%
US
IXJ
+0.12%
Tip Ranks·
US
ARKG
+1.49%
US
BBH
+0.32%
US
IXJ
+0.12%
© 2026 Longbridge｜Disclaimer